Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 106–120 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5633 BSCL2 Gene SPG17 Genetic Test This test evaluates the BSCL2 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 17 (SPG17).	Peripheral whole blood (EDTA tube), extracted genomic DNA, or FTA card blood spot	3 to 4 weeks from receipt of specimen	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSCL2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Splice-site alterations"] Parameters [] Preparation ["No fasting required", "No special dietary restrictions", "Mandatory pre-test genetic counselling session"] Indications ["Suspected diagnosis of Hereditary Spastic Paraplegia Type 17", "Family history of SPG17", "Genetic counselling for neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21665-9 ICD-10: G11.4, Z13.71 Clinical summary This test evaluates the BSCL2 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 17 (SPG17).
TEST-3870 BSND Gene (Bartter Syndrome Type 4A) Genetic Test This genetic test analyzes the BSND gene for pathogenic variants associated with Bartter Syndrome Type 4A.	Whole Blood (EDTA) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSND gene"] Parameters [] Preparation ["Prior genetic counselling session", "Documented three-generation pedigree"] Indications ["Suspected Bartter Syndrome Type 4A", "Unexplained hypokalemia", "Unexplained metabolic alkalosis", "Sensorineural hearing loss", "Family history of Bartter Syndrome Type 4A", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81313-4 ICD-10: E26.81 Clinical summary This genetic test analyzes the BSND gene for pathogenic variants associated with Bartter Syndrome Type 4A.
TEST-3385 BTK Gene (X-Linked Agammaglobulinemia Type 1) Genetic Test This genetic test identifies mutations in the BTK gene responsible for X-linked agammaglobulinemia (XLA).	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BTK gene mutations", "Copy Number Variations (CNV) in BTK gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion (within 2 weeks)"] Indications ["Suspected X-linked agammaglobulinemia (XLA)", "Recurrent sinopulmonary infections", "Low immunoglobulin levels", "Absent B-cells"] Measurement technique Confirm with laboratory Codes LOINC: 55221-2 ICD-10: D80.0 Clinical summary This genetic test identifies mutations in the BTK gene responsible for X-linked agammaglobulinemia (XLA).
TEST-3351 BTK Gene Agammaglobulinemia and Isolated Hormone Deficiency Genetic Test This genetic test analyzes the BTK gene to detect mutations associated with X-linked agammaglobulinemia and isolated hormone deficiency.	Blood (Peripheral Whole Blood)	14–21 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BTK gene variants", "Copy Number Variations (CNV) in BTK gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions or bone marrow transplants"] Indications ["Suspected X-linked agammaglobulinemia", "Suspected isolated hormone deficiency", "Family history of BTK-related disorders", "Evaluation of borderline immunoglobulin levels"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: D80.0, E23.0, Z14.8 Clinical summary This genetic test analyzes the BTK gene to detect mutations associated with X-linked agammaglobulinemia and isolated hormone deficiency.
TEST-3302 C15orf41 Gene Congenital Dyserythropoietic Anemia Type 1B (CDAIB) Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants within the C15orf41 gene associated with Congenital Dyserythropoietic Anemia Type 1B (CDAIB).	Whole blood (EDTA), buccal swab, or FTA card	21–28 calendar days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in C15orf41 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number alterations (CNVs)"] Parameters [] Preparation ["No specific preparation required"] Indications ["Suspected congenital dyserythropoietic anemia", "Carrier detection", "Family planning", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21665-5 ICD-10: D61.09 Clinical summary This test identifies pathogenic variants within the C15orf41 gene associated with Congenital Dyserythropoietic Anemia Type 1B (CDAIB).
TEST-5303 C3 Deficiency Genetic Test This test identifies inherited mutations in the C3 gene, which are responsible for complement C3 deficiency, a primary immunodeficiency.	Blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C3 gene", "Complement C3 deficiency"] Parameters [] Preparation [] Indications ["Symptomatic patients suspected of C3 deficiency", "At-risk family members of individuals with C3 deficiency", "Pre-conception carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 21643-9 ICD-10: D84.1 Clinical summary This test identifies inherited mutations in the C3 gene, which are responsible for complement C3 deficiency, a primary immunodeficiency.
TEST-5343 C5 Gene (Complement C5) Deficiency Genetic Test This test identifies pathogenic variants in the C5 gene associated with complement component 5 deficiency.	Peripheral blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C5 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No fasting is necessary.", "Complete a genetic counselling session prior to collection.", "Bring any prior immunological or complement reports.", "Do not alter prophylactic antibiotics unless directed by your physician."] Indications ["Personal or family history of invasive meningococcal disease", "Recurrent neisserial infections", "Symptoms suggestive of a terminal complement defect"] Measurement technique Confirm with laboratory Codes LOINC: 81405-5 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C5 gene associated with complement component 5 deficiency.
TEST-4388 CACNA1A Gene Episodic Ataxia Type 2 Genetic Test This genetic test evaluates the CACNA1A gene for pathogenic variants associated with episodic ataxia type 2.	Whole Blood (EDTA tube), Extracted DNA, One‑drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1A gene", "Copy number variants in the CACNA1A gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of episodic ataxia type 2", "Family history of episodic ataxia type 2", "Differential diagnosis of ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 99803-9 ICD-10: G11.9 Clinical summary This genetic test evaluates the CACNA1A gene for pathogenic variants associated with episodic ataxia type 2.
TEST-3566 CACNA1D Gene Analysis Test This test analyzes the CACNA1D gene for mutations associated with primary aldosteronism and neurological disorders.	Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1D gene", "SNVs, indels, copy number variants (CNVs)"] Parameters [] Preparation ["No fasting or special preparation is needed", "Pre-test genetic counselling session is mandatory"] Indications ["Suspected primary aldosteronism", "Early-onset seizure disorders", "Progressive neurological abnormalities of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E26.0, G40.9 Clinical summary This test analyzes the CACNA1D gene for mutations associated with primary aldosteronism and neurological disorders.
TEST-4407 CACNA1H Genetic Susceptibility Testing for Childhood Absence Epilepsy Type 6 Test This test identifies pathogenic variants in the CACNA1H gene associated with childhood absence epilepsy type 6.	Peripheral Whole Blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1H gene"] Parameters [] Preparation ["No fasting required", "Maintain normal diet and medication schedule"] Indications ["Suspected childhood absence epilepsy type 6", "Family history of childhood absence epilepsy type 6"] Measurement technique Confirm with laboratory Codes LOINC: 95857-7 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the CACNA1H gene associated with childhood absence epilepsy type 6.
TEST-4851 CACNA1S Gene Malignant Hyperthermia Type 5 Genetic Test This genetic test identifies pathogenic variants in the CACNA1S gene associated with susceptibility to malignant hyperthermia type 5 (MHS5).	Whole Blood (EDTA) or FTA Card Drop	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1S gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting or special preparation required", "Mandatory pre-test genetic counselling session required", "Complete clinical history and three-generation pedigree chart required", "Signed informed consent form required"] Indications ["Pre-anesthetic risk stratification", "Family cascade screening", "Evaluation of unexplained perioperative complications", "Assessment of muscle channelopathies"] Measurement technique Confirm with laboratory Codes LOINC: 94869-5 ICD-10: Z15.09 Clinical summary This genetic test identifies pathogenic variants in the CACNA1S gene associated with susceptibility to malignant hyperthermia type 5 (MHS5).
TEST-5823 CACNA1S Gene: Thyrotoxic Periodic Paralysis Type 1 Genetic Test This genetic test identifies pathogenic variants in the CACNA1S gene associated with thyrotoxic periodic paralysis type 1.	Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CACNA1S gene coding exons and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected thyrotoxic periodic paralysis type 1", "Family history of periodic paralysis", "Differential diagnosis of episodic weakness"] Measurement technique Confirm with laboratory Codes LOINC: 48019-1 ICD-10: G72.3 Clinical summary This genetic test identifies pathogenic variants in the CACNA1S gene associated with thyrotoxic periodic paralysis type 1.
TEST-3973 CAMTA1 Gene Genetic Test for Non-Progressive Cerebellar Ataxia with Intellectual Disability This test evaluates the CAMTA1 gene for pathogenic variants associated with non-progressive cerebellar ataxia and intellectual disability.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAMTA1 gene variants", "Pathogenic mutations", "Likely pathogenic mutations", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [{"name": "CAMTA1 Gene Analysis", "reference_range": "No pathogenic or likely pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Diagnosis of non-progressive cerebellar ataxia with intellectual disability", "Genetic counseling for affected families", "Carrier screening in families with known CAMTA1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 94222-6 ICD-10: G11.2, F70 Clinical summary This test evaluates the CAMTA1 gene for pathogenic variants associated with non-progressive cerebellar ataxia and intellectual disability.
TEST-5364 CARD11 Gene B-Cell Expansion with NF-κB and T-Cell Anergy Genetic Test This genetic test evaluates the entire CARD11 gene for variants associated with B-cell expansion, NF-κB pathway dysregulation, and T-cell anergy.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CARD11 gene variants", "Gain-of-function variants", "Loss-of-function variants", "NF-κB pathway overactivation", "T-cell anergy"] Parameters [{"name": "CARD11 Gene Coverage", "reference_range": "Full gene coverage (exons + splice sites)"}, {"name": "Mean Sequencing Depth", "reference_range": "500x"}, {"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["A detailed clinical history is required.", "A genetic counselling session is required before sample collection.", "Inform the team of any recent blood transfusions or hematopoietic cell therapy.", "No fasting or medication discontinuation is necessary unless advised by a physician."] Indications ["Diagnosis of primary immunodeficiencies (e.g., BENTA disease, CADINS syndrome)", "Evaluation of unexplained lymphoproliferation", "Assessment of lymphoma risk in patients with immune dysregulation"] Measurement technique Confirm with laboratory Codes LOINC: 55217-0 ICD-10: D84.9 Clinical summary This genetic test evaluates the entire CARD11 gene for variants associated with B-cell expansion, NF-κB pathway dysregulation, and T-cell anergy.
TEST-3742 CASR Gene Hyperparathyroidism, Neonatal Severe (Genetic Test) This genetic test identifies pathogenic mutations within the CASR gene, the primary cause of neonatal severe primary hyperparathyroidism (NSHPT).	Whole Blood (Peripheral) or Dried Blood Spot (FTA Card)	3–4 Weeks (Expedited Available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the CASR gene", "Coverage of coding regions and splice sites"] Parameters [] Preparation [] Indications ["Newborns presenting with symptoms suggestive of neonatal severe primary hyperparathyroidism (NSHPT)", "Confirmation of suspected NSHPT based on clinical presentation and biochemical findings (hypercalcemia, elevated PTH)"] Measurement technique Confirm with laboratory Codes LOINC: 51966-2 ICD-10: E21.0 Clinical summary This genetic test identifies pathogenic mutations within the CASR gene, the primary cause of neonatal severe primary hyperparathyroidism (NSHPT).

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.